Poly(p-phenylenevinylene) nanoparticles modified with antiEGFRvIII for specific glioblastoma therapy
Crossref DOI link: https://doi.org/10.1038/s41598-021-83931-5
Published Online: 2021-02-24
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Liang, Yuchao
Li, Zelin
Yuan, Huanxiang
Wang, Lei
Gao, Li-Hua
Text and Data Mining valid from 2021-02-24
Version of Record valid from 2021-02-24
Article History
Received: 27 August 2020
Accepted: 8 February 2021
First Online: 24 February 2021
Competing interests
: The authors declare no competing interests.